- Home
- DAWN vs HUYA Comparison
DAWN vs HUYA Comparison
Compare DAWN & HUYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DAWN | HUYA |
|---|---|---|
| Founded | 2018 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 989.7M |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | DAWN | HUYA |
|---|---|---|
| Price | $21.20 | $3.49 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 1 |
| Target Price | ★ $27.11 | $3.50 |
| AVG Volume (30 Days) | ★ 2.3M | 1.4M |
| Earning Date | 05-25-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 71.76% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $158,182,000.00 | N/A |
| Revenue This Year | $53.52 | $8.78 |
| Revenue Next Year | $27.10 | $11.69 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 20.60 | N/A |
| 52 Week Low | $5.64 | $2.21 |
| 52 Week High | $13.20 | $4.93 |
Technical Indicators
Market Signals| Indicator | DAWN | HUYA |
|---|---|---|
| Relative Strength Index (RSI) | 82.69 | 39.13 |
| Support Level | $6.40 | $3.21 |
| Resistance Level | N/A | $3.85 |
| Average True Range (ATR) | 0.77 | 0.19 |
| MACD | 0.65 | -0.09 |
| Stochastic Oscillator | 99.73 | 10.23 |
Price Performance
Historical ComparisonAbout DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.
About HUYA HUYA Inc. American depositary shares each representing one ordinary share
Huya, officially became independent in 2016 and headquartered in Guangzhou, operates live streaming platform focused on games, esports, and interactive entertainment, and also provides game-related services such as distribution and in-game item sales. Its main livestreaming platforms include Huya Live in China and Nimo TV outside of China. As of 2024, Huya was a subsidiary of Tencent, which owned 67% of its equity stake and held 95% of the voting power.